[ad_1] A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Americans can finally get their hands on Novavax‘s newest Covid vaccine after U.S. regulators greenlighted the shot this…
[ad_1] A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. Dado Ruvic | Reuters The Food and Drug Administration on Tuesday authorized Novavax‘s updated Covid vaccine for emergency use in people ages 12 and up, putting the shot on track to roll out weeks after new jabs from…
[ad_1] Pharmacist Ani Martirosyan administers an immunization to a patient at a CVS on Tuesday, Sept. 12, 2023 in Glendale, CA. Brian Van Der Brug | Los Angeles Times | Getty Images The rollout of a new round of Covid vaccines in the U.S. is off to a bumpy start as some patients report delays…
[ad_1] A vial of the Moderna coronavirus booster vaccine targeting BA.4 and BA.5 Omicron subvariants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, Sept. 8, 2022. Hannah Beier | Reuters The Centers for Disease Control and Prevention on Tuesday recommended that all Americans ages 6 months and older receive updated Covid shots from Pfizer and…
[ad_1] A health-care worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The Food and Drug Administration on Monday approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to…
[ad_1] Artur Widak | Nurphoto | Getty Images Moderna‘s new Covid vaccine produced a strong immune response against BA.2.86, a highly mutated omicron variant that health officials are watching closely, according to clinical trial data the biotech company released Wednesday. The updated shot produced an 8.7-fold increase in protective antibodies against BA.2.86, which has been…
[ad_1] Michael Nason, 29, left, and Donna Nason, 25, right, both of Bakersfield are wearing a face mask in Union Station on Thursday, Aug. 31, 2023, in Los Angeles, CA. COVID-19 making a comeback in California. Francine Orr | Los Angeles Times | Getty Images An uptick in Covid cases and hospitalizations in the U.S.,…
[ad_1] Nikos Pekiaridis | Lightrocket | Getty Images Covid vaccine makers’ shares rose Monday as new variants of the virus emerge in the U.S. ahead of the rollout of updated shots this fall. Shares of Novavax closed more than 13% higher. Moderna‘s stock closed more than 9% higher. Shares of BioNTech, which jointly develops Covid…
[ad_1] A pharmacist prepares to administer Covid-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center in Chicago, Illinois, Sept. 9, 2022. Scott Olson | Getty Images New Covid vaccines from Pfizer, Moderna and Novavax will likely provide protection against the new “Eris” variant, now…
[ad_1] Artur Widak | Nurphoto | Getty Images Shares of Moderna rose Thursday after the biotech company hiked its full-year outlook for its Covid vaccine, its only marketable product, despite reporting a quarterly loss and sharp drop in revenue. Here’s what Moderna reported compared with Wall Street’s expectations, based on a survey of analysts by Refinitiv: Loss…
